Clinical trials
Ischemic clinical trials
Below are recruiting ischemic clinical trials, each written for real people, not researchers. We’re tracking 830 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06492265RecruitingPhase 2
Emergency stroke unit study for acute brain attacks
This trial tests a special stroke unit for people having a severe ischemic stroke (a blood clot in the brain). It aims to see if treatment within 4.5 to 6 hours after symptoms start can improve recovery. You may join if you need a procedure to remove the clot.
BeijingAges 18 years+ - NCT06498323RecruitingPhase 4
Comparing TNK vs TPA for stroke in a mobile unit
This trial compares two clot-busting medicines, TNK and TPA, given through an IV in a special ambulance (Mobile Stroke Unit) to treat acute ischemic stroke. The goal is to see which drug works better when started quickly after symptoms begin.
BangkokAges 18 years+ - NCT06511089RecruitingPhase 3
Carotid artery stenting during stroke clot removal
This trial tests whether placing a stent in a narrowed carotid artery during a procedure to remove a stroke clot improves outcomes. If you have a stroke with a blocked large artery and significant carotid narrowing, this study may be relevant to you.
GroningenAges 18 years+ - NCT06522282RecruitingPhase 3
Testing Emergency Stroke Unit for Acute Stroke (4.5-6 hours)
This trial tests a new way to treat ischemic stroke patients who arrive at the hospital 4.5 to 6 hours after symptoms start. It focuses on people eligible for a clot removal procedure, using advanced imaging to see if this approach helps them recover better.
BeijingAges 18 years+ - NCT06525168RecruitingPhase 1
Safety study of DA414 in healthy volunteers
This trial tests a new medicine called DA414 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Wuhan, Hubei.ChinaAges 18–45 - NCT06530927Recruiting
Blood clots and stroke risk study
This study looks at tiny blood clots and immune cell activity in people with or without a recent stroke. It aims to find markers that could predict stroke risk or help improve treatment.
Zurich, Canton of ZurichAges 18 years+ - NCT06545591Recruiting
Predicting stroke treatment success with a blood test
This trial studies a blood marker called sTREM to see if it can help predict outcomes after a mechanical clot removal procedure (endovascular thrombectomy) for large-vessel stroke. If you have had a stroke due to a large artery blockage within the last 24 hours and plan to have this procedure, you may be able to join.
Xuzhou, JiangsuAges 18 years+ - NCT06556485Recruiting
Early ablation for heart failure patients with heart pumps or on transplant list
This trial tests whether doing a catheter ablation early (before dangerous heart rhythms start) can help people with severe heart failure who need a heart transplant or already have an ICD. The goal is to see if this can improve outcomes.
Bad OeynhausenAges 18–99 - NCT06557135Recruiting
Arm vs. Leg Artery for Carotid Stenting
This study compares two ways to reach the blocked neck artery during a stent procedure: through an artery in your arm versus one in your groin. The goal is to see which route is safer and works better for patients who need this treatment.
Nanjing, JiangsuAges 18 years+ - NCT06559436Recruiting
Extending window for clot-busting drug in medium vessel stroke
This trial tests a clot-dissolving drug called tenecteplase given 4.5 to 24 hours after a stroke caused by a blockage in a medium-sized brain artery. It aims to see if waiting longer than usual still helps reduce disability.
Hefei, AnhuiAges 18 years+ - NCT06559475Recruiting
Testing a new aspiration catheter for large vessel stroke
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
Hefei, AnhuiAges 18 years+ - NCT06560203Recruiting
Basilar artery stroke trial for later treatment
This trial tests if endovascular therapy (a procedure to remove a clot) can help people who have had a stroke in the back part of the brain (basilar artery) and can be treated within 72 hours, even if they are not eligible for clot-dissolving medicine. The treatment may improve recovery compared to standard care alone.
Beijing, Beijing MunicipalityAges 18–80 - NCT06563687Recruiting
Continuous glucose monitoring for HIE newborns
This study tests a continuous glucose monitor (CGM) in newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen around birth. The CGM tracks sugar levels to help doctors manage care better.
AvellinoAges Up to 6 hours - NCT06575140Recruiting
Stroke recovery arm stimulation study
This study tests a noninvasive stimulation technique to help improve arm movement in people who recently had a stroke. It is for those who still have some ability to move their fingers but have significant weakness on one side.
Mexico CityAges 18–79 - NCT06578234RecruitingPhase 4
Comparing Adenosine Doses for Heart MRI
This study will compare different doses of adenosine during a heart MRI to find the best dose for measuring blood flow to the heart muscle. It is for people with known or possible coronary artery disease or heart failure, as well as healthy volunteers.
LundAges 40 years+ - NCT06591299RecruitingPhase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
Kafr ash ShaykhAges 18–75 - NCT06591338RecruitingPhase 3
Aspirin plus ticagrelor or clopidogrel for minor stroke
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
Kafr ash ShaykhAges 18–75 - NCT06591312RecruitingPhase 3
Aspirin plus another drug after minor stroke or TIA
This trial tests whether combining aspirin with a second antiplatelet drug (ticagrelor or clopidogrel) helps prevent another stroke after a mild stroke or TIA. It might lower your risk of having another event.
Kafr ash ShaykhAges 18–75 - NCT06591351RecruitingPhase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
Kafr ash ShaykhAges 18–75 - NCT06591390RecruitingPhase 3
Aspirin plus another drug for minor stroke or TIA
This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.
Kafr ash ShaykhAges 18–75 - NCT06591377RecruitingPhase 3
Aspirin plus a second drug for minor stroke or TIA
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
CairoAges 18–75 - NCT06352619Recruiting
Lowering blood pressure after clot removal for stroke
This trial tests whether lowering blood pressure soon after a clot-removal procedure for stroke can improve recovery. It is for people whose blood pressure remains high after the procedure.
Sydney, New South WalesAges 18 years+ - NCT07091682Recruiting
A trial of a dissolvable heart stent for long blockages
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
ErfurtAges 18–80 - NCT07220538RecruitingPhase 4
Ginkgo biloba for memory problems after a mild stroke
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
AnyangAges 55 years+
Hear when a new Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic?
- Yes. Clin2 currently lists 830 recruiting ischemic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.